CoChat

The Many Microenvironments of Ovarian Cancer

Open access
Micek, Hannah M., Visetsouk, Mike R., Fleszar, Andrew J., Kreeger, Pamela K. · 2020 · Advances in experimental medicine and biology

The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.

Abstract

High-grade serous ovarian cancer (HGSOC) is the most common and deadly subtype of ovarian cancer as it is commonly diagnosed after substantial metastasis has already occurred. The past two decades have been an active era in HGSOC research, with new information on the origin and genomic signature of the tumor cell. Additionally, studies have begun to characterize changes in the HGSOC microenvironment and examine the impact of these changes on tumor progression and response to therapies. While this knowledge may provide valuable insight into better prognosis and treatments for HGSOCs, its collection, synthesis, and application are complicated by the number of unique microenvironments in the disease-the initiating site (fallopian tube), first metastasis (ovary), distal metastases (peritoneum), and recurrent/platinum-resistant setting. Here, we review the state of our understanding of these diverse sites and highlight remaining questions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/978-3-030-59038-3_12

Cites

108 of 108 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 108 references

Cited by

See all 16

Metadata

Authors
Micek, H. M., Visetsouk, M. R., Fleszar, A. J., & Kreeger, P. K.
Affiliations
University of Wisconsin–Madison (US)
Corresponding author
Kreeger, Pamela K.
Venue
Advances in experimental medicine and biology
Published
2020
Volume
1296
Pages
199-213
ISSN
  • 0065-2598 (ISSN-L)
  • 2214-8019
OpenAlex
W3174202789
Cited by
14
References
108
Citations by year
2026: 1 · 2025: 6 · 2024: 2 · 2023: 4 · 2022: 1
FWCI
8.17
Type
book chapter
Language
en
Open access
Licence
Locations
  • Advances in experimental medicine and biology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Cancer Institute (R01CA232517, R21CA227922, R01CA240965)
Topics
  • Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Health Sciences › Medicine › Surgery › Intraperitoneal and Appendiceal Malignancies
Keywords
high-grade serous ovarian cancer, tumor microenvironment, fallopian tube origin, peritoneal carcinomatosis, platinum resistance, recurrent ovarian cancer, tumor progression, treatment response, prognosis
MeSH terms
Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Fallopian Tubes, Female, Humans, Ovarian Neoplasms, Cystadenocarcinoma, Serous, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Many Microenvironments of Ovarian Cancer. https://app.cochat.ai/papers/10.1007/978-3-030-59038-3_12
The paper
Micek, H. M., Visetsouk, M. R., Fleszar, A. J., & Kreeger, P. K. (2020). The Many Microenvironments of Ovarian Cancer. Advances in experimental medicine and biology. https://doi.org/10.1007/978-3-030-59038-3_12

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.